Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Cardiology

• Publication date

  2010-07-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2008.12.068PMID 19162347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ethical authorship and publishing.

  2009cited by this paper
• Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis

  2007cited by this paper
• Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis.

  2007cited by this paper
• Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.

  2006cited by this paper
• Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more).

  2006cited by this paper
• Lipotoxicity, overnutrition and energy metabolism in aging.

  2006cited by this paper
• Distribution of SPARC during neovascularisation of degenerative aortic stenosis

  2006cited by this paper
• The apoB/apoA‐I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid‐lowering therapy – a review of the evidence

  2006cited by this paper
• Resistin is secreted from macrophages in atheromas and promotes atherosclerosis.

  2006cited by this paper
• Atorvastatin Inhibits Hypercholesterolemia-Induced Calcification in the Aortic Valves via the Lrp5 Receptor Pathway

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Resistin Is an Inflammatory Marker of Atherosclerosis in Humans

  2005cited by this paper
• A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis.

  2005cited by this paper
• Age-related changes in aortic valve with emphasis on the relation between pressure loading and thickened leaflets of the aortic valves.

  2005cited by this paper
• Hyperlipidaemia and aortic valve disease

  2004cited by this paper
• The current biology of resistin

  2004cited by this paper
• CALCIFIC AORTIC STENOSIS: FROM BENCH TO THE BEDSIDE—EMERGING CLINICAL AND CELLULAR CONCEPTS

  2003cited by this paper
• Unique lipoprotein phenotype and genotype associated with exceptional longevity.

  2003cited by this paper
• Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.

  2003cited by this paper
• Resistin is expressed in human macrophages and directly regulated by PPARγ activators

  2003cited by this paper
• Resistin Promotes Endothelial Cell Activation: Further Evidence of Adipokine-Endothelial Interaction

  2003cited by this paper
• Lipotoxic diseases.

  2002cited by this paper
• Leptin resistance during aging is independent of fat mass.

  2002cited by this paper
• Monocyte/Macrophage Regulation of Vascular Calcification In Vitro

  2002cited by this paper
• Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity.

  2001cited by this paper
• Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits.

  2000cited by this paper
• Segregation analysis of apolipoproteins A-1 and B-100 measured before and after an exercise training program: the HERITAGE Family Study.

  2000cited by this paper
• Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves.

  1999cited by this paper
• Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

  1997cited by this paper
• Clinical Factors Associated With Calcific Aortic Valve Disease

  1997cited by this paper
• Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis.

  1996cited by this paper
• Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)

  1995cited by this paper
• Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies

  1994cited by this paper
• Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

  1993cited by this paper

• Progression of stenosis severity and aortopathy in adult patients with congenital aortic stenosis

  2025cites this paper
• Methazolamide Can Treat Atherosclerosis by Increasing Immunosuppressive Cells and Decreasing Expressions of Genes Related to Proinflammation, Calcification, and Tissue Remodeling

  2024cites this paper
• Regulation of cardiovascular health and disease by visceral adipose tissue‐derived metabolic hormones

  2022cites this paper
• Determinants of Aortic Stenosis Progression in Bicuspid and Tricuspid Aortic Valves

  2022cites this paper
• Development and validation of a new prediction model for calcific aortic valve stenosis

  2022cites this paper
• Changing epidemiology of calcific aortic valve disease: 30-year trends of incidence, prevalence, and deaths across 204 countries and territories

  2021cites this paper
• Age, Sex, and Valve Phenotype Differences in Fibro‐Calcific Remodeling of Calcified Aortic Valve

  2020cites this paper
• Modulatory Role of SIRT1 and Resistin as Therapeutic Targets in Patients with Aortic Valve Stenosis.

  2019cites this paper
• Aortic stenosis: what is the role of aging processes?

  2019cites this paper
• Molecular Mechanisms of Aortic Valve Pathology

  2019cites this paper
• Association Between Serum Leptin Level and Calcific Aortic Valve Disease

  2019cites this paper
• Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women.

  2018cites this paper
• ApoB/ApoA‐I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study

  2018cites this paper
• Postimplant biological aortic prosthesis degeneration: challenges in transcatheter valve implants

  2018cites this paper
• Comparison of Lipoprotein(a)-Levels in Patients ≥70 Years of Age With Versus Without Aortic Valve Stenosis.

  2018cites this paper
• CD133+ cells are associated with ADIPOCYTOKINES and endothelial dysfunction in hemodialysis patients

  2017cites this paper
• Epigenome alterations in aortic valve stenosis and its related left ventricular hypertrophy

  2017cites this paper
• Oxidized Phospholipids, Lipoprotein(a), and Progression of Calci fi c Aortic Valve Stenosis

  2017cites this paper
• RNA expression profile of calcified bicuspid, tricuspid, and normal human aortic valves by RNA sequencing.

  2016cites this paper
• Altered DNA Methylation of Long Noncoding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1

  2016cites this paper
• Calcific aortic stenosis

  2016cites this paper
• Relevance Study on Cerebral Infarction and Resistin Gene Polymorphism in Chinese Han Population

  2016cites this paper
• Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease

  2016cites this paper
• Association of coronary artery calcium with bone mineral density in postmenopausal women

  2016cites this paper
• Molecular mechanisms of calcific aortic valve disease

  2015cites this paper
• Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study.

  2015cites this paper
• Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.

  2015cites this paper
• Novel Inflammatory Indices in Aortic Disease.

  2015cites this paper
• Association between Low Serum Fetuin A, Ischaemic Heart and Early Chronic Kidney Disease

  2015influential citation
• Basic mechanisms of calcific aortic valve disease.

  2014cites this paper
• Circulating levels of matrix gla protein and progression of aortic stenosis: a substudy of the Aortic Stenosis Progression Observation: Measuring Effects of rosuvastatin (ASTRONOMER) trial.

  2014cites this paper
• Evaluation of Links Between High-Density Lipoprotein Genetics, Functionality, and Aortic Valve Stenosis Risk in Humans

  2014cites this paper
• Impact of ethnicity on cardiac adaptation to exercise

  2014cites this paper
• Aortic stenosis: new pathophysiological mechanisms and their therapeutic implications.

  2014cites this paper
• Potential drug targets for calcific aortic

  2014cites this paper
• Postprocedural Aortic Regurgitation in Balloon-Expandable and Self-Expandable Transcatheter Aortic Valve Replacement Procedures: Analysis of Predictors and Impact on Long-Term Mortality Insights From the FRANCE2 Registry

  2014cites this paper
• Post-Procedural Aortic Regurgitation in Balloon-expandable and Self-Expandable TAVR Procedures: Analysis of Predictors and Impact on Long-Term Mortality: Insights from the FRANCE2 Registry

  2014cites this paper
• Ectopic visceral fat: A clinical and molecular perspective on the cardiometabolic risk

  2014cites this paper
• Severe degenerative aortic stenosis with preserved ejection fraction does not change adipokines serum levels

  2013cites this paper
• The genetic and metabolic determinants of cardiovascular complications in type 2 diabetes: recent insights from animal models and clinical investigations.

  2013cites this paper
• Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy.

  2012cites this paper
• Underestimation of aortic valve area in calcified aortic valve disease: effects of left ventricular outflow tract ellipticity.

  2012cites this paper
• Sirt1 Inhibits Resistin Expression in Aortic Stenosis

  2012cites this paper
• Occurrence of cardiovascular calcifications in normal, aging rats.

  2012cites this paper
• Differences in coronary plaque composition with aging measured by coronary computed tomography angiography.

  2012cites this paper
• Differentiation of Dementia with Lewy Bodies from Alzheimer's Disease Using the Japanese Version of the Test Your Memory

  2012cites this paper
• The Relationship Between Serum Resistin Level and the Components of Metabolic Syndrome in Elderly Chinese Men

  2012cites this paper
• Mechanisms of Disease: Novel Polymorphisms in Coronary Artery Disease

  2011cites this paper
• Reduced Fetuin A Serum Level is Associated with Faster Stenosis Progression and Increased Valvular Calcification in Elderly Patients with Aortic Stenosis

  2011cites this paper
• Valvular Heart Disease in Aging Women

  2011cites this paper
• 1 Mechanisms of Disease : Novel Polymorphisms in Coronary Artery Disease

  2011cites this paper
• Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease.

  2011cites this paper
• ESTENOSE AÓRTICA DEGENERATIVA: HISTÓRIA NATURAL E PERFIL DE FACTORES DE RISCO

  2010cites this paper
• Association of resistin polymorphism, its serum levels and prevalence of stroke in Japanese type 2 diabetic patients

  2010cites this paper
• Obesity, Inflammation, and Cardiovascular Risk

  2010cites this paper
• The Pathogenesis and Treatment of the Valvulopathy of Aortic Stenosis: Beyond the SEAS

  2010cites this paper